Yoshida K - Search Results

1

Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.

Takai T, Kanaoka S, Yoshida K, Hamaya Y, Ikuma M, Miura N, Sugimura H, Kajimura M, Hishida A. Takai T, et al. Among authors: yoshida k. Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1888-93. doi: 10.1158/1055-9965.EPI-08-0937. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19505922

2

Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer.

Hamaya Y, Yoshida K, Takai T, Ikuma M, Hishida A, Kanaoka S. Hamaya Y, et al. Among authors: yoshida k. Br J Cancer. 2010 Mar 2;102(5):916-21. doi: 10.1038/sj.bjc.6605564. Epub 2010 Feb 9. Br J Cancer. 2010. PMID: 20145612 Free PMC article.

3

Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.

Kanaoka S, Yoshida K, Miura N, Sugimura H, Kajimura M. Kanaoka S, et al. Among authors: yoshida k. Gastroenterology. 2004 Aug;127(2):422-7. doi: 10.1053/j.gastro.2004.05.022. Gastroenterology. 2004. PMID: 15300574 Clinical Trial.

4

Cyclooxygenase-2 and tumor biology.

Kanaoka S, Takai T, Yoshida K. Kanaoka S, et al. Among authors: yoshida k. Adv Clin Chem. 2007;43:59-78. Adv Clin Chem. 2007. PMID: 17249380 Review.

5

A distinct expression pattern of the long 3'-untranslated region dicer mRNA and its implications for posttranscriptional regulation in colorectal cancer.

Hamaya Y, Kuriyama S, Takai T, Yoshida K, Yamada T, Sugimoto M, Osawa S, Sugimoto K, Miyajima H, Kanaoka S. Hamaya Y, et al. Among authors: yoshida k. Clin Transl Gastroenterol. 2012 Jul 26;3(7):e17. doi: 10.1038/ctg.2012.12. Clin Transl Gastroenterol. 2012. PMID: 23238289 Free PMC article.

6

EGF rapidly translocates tight junction proteins from the cytoplasm to the cell-cell contact via protein kinase C activation in TMK-1 gastric cancer cells.

Yoshida K, Kanaoka S, Takai T, Uezato T, Miura N, Kajimura M, Hishida A. Yoshida K, et al. Exp Cell Res. 2005 Oct 1;309(2):397-409. doi: 10.1016/j.yexcr.2005.06.019. Exp Cell Res. 2005. PMID: 16054131

7

A Japanese case of familial Mediterranean fever with family history demonstrating a mutation in MEFV.

Yoshida K, Kanaoka S, Kajimura M, Kataoka H, Takahira K, Osawa S, Sano M, Hishida A. Yoshida K, et al. Intern Med. 2003 Aug;42(8):761-4. doi: 10.2169/internalmedicine.42.761. Intern Med. 2003. PMID: 12924509 Free article.

8

Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma.

Osawa S, Furuta T, Sugimoto K, Kosugi T, Terai T, Yamade M, Takayanagi Y, Nishino M, Hamaya Y, Kodaira C, Yamada T, Iwaizumi M, Takagaki K, Yoshida K, Kanaoka S, Ikuma M. Osawa S, et al. Among authors: yoshida k. BMC Cancer. 2009 Nov 22;9:408. doi: 10.1186/1471-2407-9-408. BMC Cancer. 2009. PMID: 19930599 Free PMC article. Clinical Trial.

9

Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin.

Kono S, Yoshida K, Tomosugi N, Terada T, Hamaya Y, Kanaoka S, Miyajima H. Kono S, et al. Among authors: yoshida k. Biochim Biophys Acta. 2010 Nov;1802(11):968-75. doi: 10.1016/j.bbadis.2010.07.011. Epub 2010 Jul 22. Biochim Biophys Acta. 2010. PMID: 20655381 Free article.

10

SPG3A-linked hereditary spastic paraplegia associated with cerebral glucose hypometabolism.

Terada T, Kono S, Ouchi Y, Yoshida K, Hamaya Y, Kanaoka S, Miyajima H. Terada T, et al. Among authors: yoshida k. Ann Nucl Med. 2013 Apr;27(3):303-8. doi: 10.1007/s12149-012-0673-5. Epub 2012 Dec 12. Ann Nucl Med. 2013. PMID: 23233086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,868 results

Search Page

Filters